As of 2025-05-17, the Intrinsic Value of Shree Ganesh Remedies Ltd (540737.BO) is 296.06 INR. This 540737.BO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 750.10 INR, the upside of Shree Ganesh Remedies Ltd is -60.50%.
The range of the Intrinsic Value is 242.16 - 384.24 INR
Based on its market price of 750.10 INR and our intrinsic valuation, Shree Ganesh Remedies Ltd (540737.BO) is overvalued by 60.50%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 242.16 - 384.24 | 296.06 | -60.5% |
DCF (Growth 10y) | 414.21 - 654.27 | 505.84 | -32.6% |
DCF (EBITDA 5y) | 449.74 - 891.44 | 645.79 | -13.9% |
DCF (EBITDA 10y) | 618.24 - 1,226.98 | 878.13 | 17.1% |
Fair Value | 554.30 - 554.30 | 554.30 | -26.10% |
P/E | 419.05 - 767.16 | 543.28 | -27.6% |
EV/EBITDA | 255.20 - 649.96 | 449.33 | -40.1% |
EPV | 45.64 - 58.32 | 51.98 | -93.1% |
DDM - Stable | 130.45 - 273.99 | 202.22 | -73.0% |
DDM - Multi | 268.13 - 438.99 | 333.05 | -55.6% |
Market Cap (mil) | 9,631.28 |
Beta | 1.01 |
Outstanding shares (mil) | 12.84 |
Enterprise Value (mil) | 9,823.22 |
Market risk premium | 8.31% |
Cost of Equity | 13.59% |
Cost of Debt | 7.46% |
WACC | 13.30% |